RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling

Osteosarcoma (OS) is the most common primary malignancy of the bone that predominantly affects children and adolescents. Hippo pathway is a crucial regulator of organ size and tumorigenesis. However, how Hippo pathway regulates the occurrence of osteosarcoma is largely unknown. Here, we reported the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Liu, Min, Yang, Shuting, Fuller, Ashley M., Eisinger, T. S. Karin, Yang, Shuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694668/
https://www.ncbi.nlm.nih.gov/pubmed/33686240
http://dx.doi.org/10.1038/s41388-020-01599-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694668/
https://www.ncbi.nlm.nih.gov/pubmed/33686240
http://dx.doi.org/10.1038/s41388-020-01599-z

Ejemplares similares